ArticleExperimental hematology & oncology2025

CD47 antibody-armed oncolytic adenovirus promotes chimeric antigen receptor macrophage phagocytosis and antitumor immunity.

Zhongbing Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.